CLINICAL CASE OF REMOVING SUPRACEREBELLAR TUMOR OF POSTERIOR CRANIAL FOSSA.

Abstract

Medulloblastoma (MB) is an embryonal tumor originating from the midline
cerebellum with the potential for leptomeningeal spread [1]. MBs account for 61.9% of all
posterior fossa embryonal tumors and account for 14.3% of childhood mortality [2–5]. Early
diagnosis of MB is difficult due to the initial nonspecific clinical symptoms, especially in very
young children. The most common signs of posterior fossa space-occupying lesions are
symptoms of intracranial hypertension, visual and cerebellar disturbances, as well as seizures,
behavioral changes, and cranial nerve deficits [6–9]